Literature DB >> 12676504

Purification and characterization of acidic proteo-heteroglycan from the fruiting body of Phellinus linteus (Berk. & M.A. Curtis) Teng.

Gi-Young Kim1, Hyung-Sik Park, Byong-Hyok Nam, Sang-Jun Lee, Jae-Dong Lee.   

Abstract

Phellinus linteus is a well-known oriental medicinal fungus that has various biological activities such as stimulation of humoral and cell mediated immunity, anti-mutagenicity activity, and anti-cancer activity. The process of isolating and purifying a water-soluble glycan from P. linteus was achieved by hot water extraction, filtration, solvent precipitation, dialysis, and freeze-drying. Acidic fractions of the polysaccharide were separated from crude polysaccharides by DEAE-cellulose anion exchange chromatography at 0.4 M NaCl. The molecular weight of the proteo-heteroglycan after Sepharose CL-4B gel filtration chromatography was about 150,000. The acidic proteo-heteroglycan consisted of 72.2% polysaccharide and 22.3% protein. The sugar of the proteo-heteroglycan was composed of mannose, galactose, glucose, arabinose, and xylose. The amino acid pattern showed that the fractions contained large amounts of aspartic acid, glutamic acid, alanine, glycine, and serine. The fractions for both alpha-glycan at 860 cm(-1) and beta-glycan at 910 cm(-1) had the characteristics of IR spectrum absorption as compared to those for beta-glucan derived from Lentinus edodes. A 13C and 1H NMR spectroscopy showed that the acidic proteo-heteroglycan was a noble biomolecule mixed both alpha- and beta-linkages, and a (1,6) branched type (1,3) glycan.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676504     DOI: 10.1016/s0960-8524(02)00273-0

Source DB:  PubMed          Journal:  Bioresour Technol        ISSN: 0960-8524            Impact factor:   9.642


  8 in total

1.  [Preparation and antitumor activity of sulfated exopolysaccharide from Rhizopus nigricans].

Authors:  Guozheng Qin; Taili Shao; Ping Li; Yuyan Zhou; Yan Li; Xuchen Hong; Zhang Li; Guodong Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2019-10-30

2.  Comparison of intraperitoneal anti-adhesive polysaccharides derived from Phellinus mushrooms in a rat peritonitis model.

Authors:  Jae-Sung Bae; Kwang-Ho Jang; Hee-Kyung Jin
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

3.  Inhibitory effects of polysaccharides isolated from Phellinus gilvus on benzo(a)pyrene-induced forestomach carcinogenesis in mice.

Authors:  Jae-Sung Bae; Kwang-Ho Jang; Hyunee Yim; Seung-Chun Park; Hee-Kyung Jin
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

4.  Medicinal mushrooms: Towards a new horizon.

Authors:  A Ganeshpurkar; G Rai; A P Jain
Journal:  Pharmacogn Rev       Date:  2010-07

5.  Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling.

Authors:  D Sliva; A Jedinak; J Kawasaki; K Harvey; V Slivova
Journal:  Br J Cancer       Date:  2008-03-25       Impact factor: 7.640

6.  Selenium-Containing Exopolysaccharides Isolated from the Culture Medium of Lentinula edodes: Structure and Biological Activity.

Authors:  Sandra Górska-Jakubowska; Marzenna Klimaszewska; Piotr Podsadni; Beata Kaleta; Radosław Zagożdżon; Sabina Górska; Andrzej Gamian; Tomasz Strączek; Czesław Kapusta; Marcin Cieślak; Julia Kaźmierczak-Barańska; Barbara Nawrot; Jadwiga Turło
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

Review 7.  Current advances and potential trends of the polysaccharides derived from medicinal mushrooms sanghuang.

Authors:  Hao Wang; Jin-Xin Ma; Miao Zhou; Jing Si; Bao-Kai Cui
Journal:  Front Microbiol       Date:  2022-08-03       Impact factor: 6.064

8.  Antitumor and Antioxidant Activities of the Extracts from Fruiting Body of Phellinus linteus.

Authors:  June Woo Lee; Seong Jin Baek; Woo Chul Bae; Jeong Min Park; Yong Seok Kim
Journal:  Mycobiology       Date:  2006-12-31       Impact factor: 1.858

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.